Sigyn Therapeutics Appoints Alexander S. Yevzlin, MD, FASN to Its Scientific Advisory Board
Dr. Yevzlins considerable extracorporeal industry experience and insight is expected to contribute to the clinical advancement of Sigyn Therapy.
- Dr. Yevzlins considerable extracorporeal industry experience and insight is expected to contribute to the clinical advancement of Sigyn Therapy.
- Sigyn Therapeutics is a medical technology company focused on the treatment of pathogen-associated conditions that precipitate sepsis, the leading cause of hospital deaths worldwide.
- This information in this press release contains forward-looking statements of Sigyn Therapeutics, Inc. (Sigyn) that involve substantial risks and uncertainties.
- All forward-looking statements contained in this report speak only as of the date on which they were made.